SCHEMBL6671788

SCHEMBL6671788

Nc1ncnc2c1ncn2C1OC(C(O)O)C(O)C1O

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHCY P23526 11/20 0.67
▸ PRMT5 O14744 1/20 0.67
▸ WDR77 Q9BQA1 1/20 0.67
▸ ADORA2A P29274 2/20 0.66
▸ ADORA2B P29275 2/20 0.66
▸ ADORA3 P0DMS8 2/20 0.66
▸ DPP4 P27487 1/20 0.66
▸ MEN1 O00255 1/20 0.66
▸ SLC28A1 O00337 1/20 0.66
▸ MAP3K7 O43318 1/20 0.66
▸ SLC28A2 O43868 1/20 0.66
▸ GAPDH P04406 1/20 0.66
▸ MAPK1 P28482 1/20 0.66
▸ ADORA1 P30542 1/20 0.66
▸ STAT6 P42226 1/20 0.66
▸ PI4KA P42356 1/20 0.66
▸ KMT2A Q03164 1/20 0.66
▸ SMN1; SMN2 Q16637 1/20 0.66
▸ PI4K2B Q8TCG2 1/20 0.66
▸ DOT1L Q8TEK3 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7803295 1.00 AHCY (0.67) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL31680251 0.94 AHCY (0.68) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL397800 0.94 AHCY (0.68) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL2040666 0.91 PRMT5 (0.66) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL10997934 0.90 AHCY (0.65) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL21413837 0.90 PRMT5 (0.64) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL16300875 0.90 PRMT5 (0.64) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL22326785 0.90 PRMT5 (0.64) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL22326787 0.90 PRMT5 (0.64) AHCYPRMT5WDR77ADORA2AADORA2B
SCHEMBL800346 0.90 PRMT5 (0.64) AHCYPRMT5WDR77ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160144031-A1 Photo-Responsive Compounds NIH-DEITR 2016-05-26 — — US disclosed
WO-2004037159-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING FAT METABOLISM OBETHERAPY BIOTECHNOLOGY (FR) 2004-05-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160144031-A1 Photo-Responsive Compounds CD47, HMBS, ALDH1A2 AHCY 93/4885PRMT5 1951/4885WDR77 2818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback